VRTX - Vertex Pharmaceuticals Inc / Ma - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - VRTX (875320)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-12-09
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$225.00-5,00053,262-9%-$1,125,000
D
2019-11-25
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$220.00-5,00053,262-9%-$1,100,000
D
2019-11-25
VRTXKewalramani ReshmaEVP, CMOS - Sale+OE$219.37-4,69213,098-26%-$1,029,284
D
2019-11-25
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$219.37-3,91031,553-11%-$857,737
D
2019-11-19
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$210.91-96,534106,786-47%-$20,360,052
D
2019-11-19
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$215.00-5,00053,262-9%-$1,075,000
2019-11-15
VRTXTatsis OuraniaSVP, CROS - Sale$205.95-57,2520%-$1,030
2019-11-15
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale$205.95-5753,2620%-$11,739
2019-11-15
VRTXParini MichaelEVP, CL, AOS - Sale$205.95-8435,0030%-$17,300
DM
2019-11-15
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$210.00-9,434106,786-8%-$1,981,140
2019-11-15
VRTXKewalramani ReshmaEVP, CMOS - Sale$205.95-6113,0980%-$12,563
2019-11-15
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$205.95-1933,3800%-$3,913
2019-11-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$205.95-6031,5530%-$12,357
D
2019-11-13
VRTXTatsis OuraniaSVP, CROS - Sale+OE$205.59-2,8537,252-28%-$586,548
D
2019-11-13
VRTXParini MichaelEVP, CL, AOS - Sale+OE$205.50-4,89235,003-12%-$1,005,306
D
2019-11-13
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$205.57-8,56033,380-20%-$1,759,679
D
2019-11-08
VRTXKewalramani ReshmaEVP, CMOS - Sale+OE$199.00-50913,098-4%-$101,291
D
2019-11-06
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$197.21-1,22331,553-4%-$241,189
D
2019-11-04
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$200.34-4,09753,262-7%-$820,795
D
2019-11-04
VRTXParini MichaelEVP, CL, AOS - Sale+OE$200.50-2,33035,003-6%-$467,168
D
2019-11-04
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$201.62-3,70833,380-10%-$747,607
D
2019-11-04
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$200.45-4,12631,553-12%-$827,049
DM
2019-10-31
VRTXKearney Terrence CDirS - Sale+OE$200.00-52,4485,811-90%-$10,489,600
DM
2019-10-31
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$200.01-105,701106,727-50%-$21,141,792
D
2019-11-01
VRTXBhatia Sangeeta N.DirS - Sale+OE$200.00-1,2915,249-20%-$258,200
D
2019-10-30
VRTXKewalramani ReshmaEVP, CMOS - Sale+OE$199.00-3,05713,098-19%-$608,343
D
2019-10-25
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$195.01-4,31153,262-7%-$840,688
D
2019-10-22
VRTXSachdev AmitEVP, Chief Patient OfficerS - Sale+OE$190.27-3,88353,262-7%-$738,818
D
2019-10-22
VRTXMcGlynn Margaret GDirS - Sale+OE$190.00-20,0004,124-83%-$3,800,000
D
2019-10-22
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$190.00-107,831106,727-50%-$20,487,890
2019-10-22
VRTXKewalramani ReshmaEVP, CMOS - Sale$189.00-63813,098-5%-$120,582
D
2019-10-22
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$194.37-3,66931,553-10%-$713,144
D
2019-10-17
VRTXParini MichaelEVP, CL, AOS - Sale+OE$177.80-4,25035,003-11%-$755,650
D
2019-10-14
VRTXParini MichaelEVP, CL, AOS - Sale+OE$174.06-2,12535,003-6%-$369,885
D
2019-10-02
VRTXBhatia Sangeeta N.DirS - Sale+OE$166.80-8,3795,249-61%-$1,397,640
M
2019-10-01
VRTXTatsis OuraniaSVP, CROS - Sale$168.11-6327,252-8%-$106,247
D
2019-08-19
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$186.38-12,50131,553-28%-$2,329,976
D
2019-08-13
VRTXMcGlynn Margaret GDirS - Sale+OE$185.00-10,0004,124-71%-$1,850,000
D
2019-08-08
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$181.89-2,12533,380-6%-$386,516
D
2019-08-05
VRTXParini MichaelEVP, CL, AOS - Sale+OE$175.28-2,33035,003-6%-$408,399
DM
2019-08-02
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$177.22-3,70832,380-10%-$657,127
D
2019-07-12
VRTXParini MichaelEVP, CL, AOS - Sale+OE$175.27-2,12535,003-6%-$372,455
D
2019-07-05
VRTXParini MichaelEVP, CL, AOS - Sale+OE$179.12-4,25035,003-11%-$761,239
D
2019-06-19
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$181.89-2,12533,380-6%-$386,516
D
2019-06-18
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$175.39-56,030106,727-34%-$9,827,054
2019-06-03
VRTXBhatia Sangeeta N.DirS - Sale$167.08-7206,540-10%-$120,298
D
2019-05-24
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$175.10-113,432106,727-52%-$19,861,943
2019-05-15
VRTXSachdev AmitEVP, CROS - Sale$165.41-6153,2620%-$10,090
2019-05-15
VRTXSilva Paul MSVP, ControllerS - Sale$165.41-16117,928-1%-$26,631
2019-05-15
VRTXParini MichaelEVP, CL, AOS - Sale$165.41-8335,0030%-$13,729
2019-05-15
VRTXKewalramani ReshmaEVP, CMOS - Sale$165.41-24113,736-2%-$39,864
2019-05-15
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$165.41-13333,3800%-$22,000
2019-05-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$165.41-9131,5530%-$15,052
D
2019-05-06
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$175.01-33,058215,130-13%-$5,785,504
DM
2019-05-03
VRTXParini MichaelEVP, CL, AOS - Sale+OE$172.34-2,32971,835-3%-$401,385
DM
2019-05-02
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$170.57-3,70867,933-5%-$632,491
D
2019-05-01
VRTXLeiden Jeffrey MCEO, PresS - Sale+OE$175.08-10,480106,635-9%-$1,834,826
D
2019-04-16
VRTXParini MichaelEVP, CL, AOS - Sale+OE$181.99-6,37535,003-15%-$1,160,166
2019-04-15
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$181.75-5,62433,240-14%-$1,022,148
2019-02-19
VRTXSilva Paul MSVP, Interim CFOS - Sale$186.97-2,81217,928-14%-$525,747
2019-02-19
VRTXParini MichaelEVP, CL, AOS - Sale$186.98-5,62435,003-14%-$1,051,585
2019-02-19
VRTXLeiden Jeffrey MCEO, PresS - Sale$186.98-20,997106,635-16%-$3,926,113
2019-02-19
VRTXKewalramani ReshmaEVP, CMOS - Sale$186.94-1,48813,736-10%-$278,163
2019-02-19
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$187.00-5,62431,553-15%-$1,051,716
2019-02-11
VRTXSachdev AmitEVP, CROS - Sale$180.06-35,09553,262-40%-$6,319,216
2019-02-11
VRTXLeiden Jeffrey MCEO, PresS - Sale$180.24-111,431127,632-47%-$20,083,804
2019-02-11
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$180.21-33,07339,004-46%-$5,959,969
2019-02-11
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$180.22-32,95637,177-47%-$5,939,188
2019-02-11
VRTXParini MichaelEVP, CL, AOS - Sale$180.22-12,13640,627-23%-$2,187,190
2019-02-11
VRTXSilva Paul MSVP, Interim CFOS - Sale$180.16-4,21520,740-17%-$759,367
D
2019-02-06
VRTXSilva Paul MSVP, Interim CFOS - Sale+OE$193.00-1,28912,818-9%-$248,777
D
2019-02-04
VRTXSachdev AmitEVP, CROS - Sale+OE$186.87-12,72251,134-20%-$2,377,296
D
2019-02-04
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$186.20-18,30936,542-33%-$3,409,082
D
2019-02-04
VRTXSilva Paul MSVP, Interim CFOS - Sale+OE$187.02-4,24712,649-25%-$794,273
2019-02-04
VRTXLeiden Jeffrey MCEO, PresS - Sale$186.35-32,250125,305-20%-$6,009,682
D
2019-02-04
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$189.19-4,12639,113-10%-$780,598
D
2019-02-04
VRTXParini MichaelEVP, CL, AOS - Sale+OE$189.19-2,33036,159-6%-$440,813
2019-02-01
VRTXParini MichaelEVP, CL, AOS - Sale$190.92-3,45036,159-9%-$658,674
D
2019-01-22
VRTXParini MichaelEVP, CL, AOS - Sale+OE$195.00-3,66839,609-8%-$715,260
D
2019-01-22
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$193.48-2,12546,892-4%-$411,145
D
2019-01-22
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$193.48-2,12539,113-5%-$411,145
D
2019-01-18
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$194.62-1,22339,113-3%-$238,020
D
2019-01-17
VRTXSilva Paul MSVP, Corp ControllerS - Sale+OE$190.62-3,00716,256-16%-$573,182
D
2019-01-14
VRTXParini MichaelEVP, CL, AOS - Sale+OE$186.71-2,12539,609-5%-$396,759
D
2019-01-04
VRTXParini MichaelEVP, CL, AOS - Sale+OE$165.90-4,25039,609-10%-$705,075
D
2018-12-03
VRTXSilva Paul MSVP, Corp ControllerS - Sale+OE$186.52-80916,256-5%-$150,895
2018-11-15
VRTXSilva Paul MSVP, Corp ControllerS - Sale$163.75-1216,2560%-$1,965
2018-11-15
VRTXParini MichaelEVP, CL, AOS - Sale$163.75-9039,6090%-$14,738
2018-11-15
VRTXSachdev AmitEVP, CROS - Sale$163.75-6159,7590%-$9,989
2018-11-15
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$163.75-2946,8920%-$4,749
2018-11-15
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale$163.75-10039,1130%-$16,375
D
2018-11-07
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$179.00-2,12546,892-4%-$380,375
D
2018-11-07
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$181.89-2,12539,113-5%-$386,516
DM
2018-11-02
VRTXSachdev AmitEVP, CROS - Sale+OE$173.27-4,09659,759-6%-$709,709
D
2018-11-05
VRTXParini MichaelEVP, CL, AOS - Sale+OE$172.08-2,33039,609-6%-$400,946
D
2018-11-05
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$172.08-5,80346,892-11%-$998,580
DM
2018-11-02
VRTXAltshuler DavidEVP, Global Research, CSOS - Sale+OE$173.51-4,12639,113-10%-$715,893
D
2018-11-02
VRTXArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$175.36-2,15546,892-4%-$377,901
D
2018-10-12
VRTXParini MichaelEVP, CL, AOS - Sale+OE$177.20-2,12539,609-5%-$376,550
2018-10-08
VRTXKewalramani ReshmaEVP, CMOS - Sale$186.95-2,3051,909-55%-$430,920
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top